BDBM50099764 4-(Carboxymethyl-carbamoyl)-4-{[1-(2-{2-[(9,10-dioxo-9,10-dihydro-phenanthrene-2-carbonyl)-amino]-acetylamino}-acetyl)-pyrrolidine-2-carbonyl]-amino}-butyric acid::CHEMBL50794

SMILES OC(=O)CCC(NC(=O)C1CCCN1C(=O)CNC(=O)CNC(=O)c1ccc-2c(c1)C(=O)C(=O)c1ccccc-21)C(=O)NCC(O)=O

InChI Key InChIKey=MVUYTXKLLGHKIE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50099764   

TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Astrazeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50099764(4-(Carboxymethyl-carbamoyl)-4-{[1-(2-{2-[(9,10-dio...)
Affinity DataIC50:  600nMAssay Description:In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed